Metabolism Supplement Guide: What The Evidence Shows

The right-hand column is the best result in the published human literature for each mechanism, not a claim about any particular product.

Two of those four are what the marketing in this aisle is about. The third is a supporting act that never appears on a front panel, and the fourth is routinely presented as though it were the first.

The distinction between substrate use and energy balance is the one that causes the most confusion. Burning a higher proportion of fat during a given hour is a real, reproducible laboratory finding. It tells you nothing on its own about whether the day ended in a deficit, which is the thing that decides whether stored fat goes anywhere.

A guide that respected the evidence would spend most of its length on the first mechanism, because that is where the numbers are. So this one does.

This is the mechanism with the most reliable evidence and the smallest effect, which is an awkward combination for a category built on it.

Caffeine is the clearest case in the literature and the easiest to reason about. A published crossover gave 100 mg, an ordinary cup of coffee, and measured the response. Work on thermogenic ingredients over longer periods and research on brown adipose tissue fill in the mechanism. The direction is consistent and the magnitude is modest.

Capsaicinoids, the pungent fraction of chilli, are the second-clearest. The pooled analysis of resting metabolic rate puts the effect at roughly 34 kcal a day. That is a real number produced by real trials, and it is about a third of an apple.

Green tea catechins are the third. A meta-analysis of catechin and caffeine mixtures found effects on weight maintenance, and an energy expenditure study measured the response directly. The doses involved are the story and they are covered further down.

That last line is the honest frame for the whole mechanism. Thirty-four calories a day is not nothing, and it is also not a strategy. It is the sort of effect that shows up in a controlled trial with a metabolic cart attached to somebody and disappears entirely into the noise of an ordinary week.

Appetite is where most of this category’s marketing lives and where its literature is least settled.

Hydroxycitric acid, the compound garcinia cambogia is grown for, is the most studied example and the most instructive. A satiety crossover used 900 mg a day and reported effects on intake. The largest randomised trial gave 1,500 mg a day for twelve weeks to 135 people and found no difference from placebo on body weight or fat mass. A meta-analysis of twelve trials later pooled everything and arrived at about 0.88 kg.

Read those three together and a pattern emerges that repeats across the category. Small studies with mechanistic endpoints find something. The largest trial with the hardest endpoint finds nothing. The pooled figure lands somewhere small and is dominated by the smaller studies.

Acetic acid, the active fraction of vinegar, tells a similar story from a different direction. The twelve-week Japanese trial gave 15 or 30 mL of liquid vinegar daily and reported modest reductions. A 2025 meta-analysis found the signal concentrated in the higher-dose subgroup, which is what a real dose response looks like.

One ingredient class on a metabolism panel is not there to do anything to metabolism at all.

Piperine, the pungent compound in black pepper, is an absorption modifier. The study that made it famous gave 20 mg of piperine alongside a poorly absorbed compound and raised its bioavailability substantially. Work on intestinal permeability describes part of the mechanism.

That makes it genuinely useful on a panel whose other rows are poorly absorbed, and it makes it worth a second thought for a different reason. Piperine is a mechanism-based inactivator of CYP3A, one of the main enzymes the body uses to clear medicines. An ingredient that raises the absorption of what is in the capsule can raise the blood level of what is in the prescription too.

This is the row to notice on any label that carries it, and it is almost never the row a front panel is talking about. If you take anything prescribed, it is the single most worthwhile sentence on the back of the bottle.

The practical reading: an absorption row is a reason a formula might work better than the sum of its amounts, and a reason to check the interaction before assuming it is inert. Both halves of that sentence are true at once.

Five results that between them describe the ceiling of this category. Each one is the best or the largest available for its mechanism.

The last row is the one worth sitting with. That trial randomised a commercial multi-ingredient thermogenic product for twelve weeks, which is precisely the thing this aisle sells, and its own authors described the changes as clinically insignificant.

There is no equivalent trial showing the opposite. The category’s strongest evidence is for isolated compounds at doses higher than commercial products carry, and its evidence for finished multi-ingredient products is thin and unflattering.

That does not make these products worthless. It makes them small, and it means anyone expecting a capsule to do the work of a diet has been sold an expectation that the literature never supported.

Two reasons, and the second one is the one almost nobody notices.

The first is volume. A trial dose is often more material than a capsule can physically hold at a sensible serving. 1,500 mg of hydroxycitric acid a day is a large amount of powder, and a formula carrying five other ingredients has no room for it.

The second is the unit. Research counts the active fraction. Labels print the extract weight. Those are different quantities and the ratio between them is set by a standardisation percentage that a label is not required to state.

So a panel reading 250 mg of green tea extract is not comparable to a trial that gave 856.8 mg of EGCG, and the gap between them cannot be computed without a percentage. Measured catechin content across commercial green tea supplements varies enough that the same extract weight can mean very different things.

Read the last row on its own and the discipline becomes obvious. Caffeine anhydrous is the only common metabolism ingredient where the label unit and the research unit are the same thing, which is exactly why it is the only row on a panel like this that can be checked in ten seconds.

Support, and nothing stronger.

A dietary supplement in the United States may carry a structure and function claim: a statement that it supports a normal bodily process. It may not claim to treat, prevent or cure anything, and it is not approved before sale. That is why the same disclaimer appears on every bottle in the aisle.

The practical consequence is a gap that a reader can use. A bottle’s own label is written under that ceiling and is therefore fairly cautious. The advertising around it frequently is not, because a banner is not a label.

So when a front panel says one modest thing and a website beside it promises something large, the modest thing is the one written under legal constraint. Trust the bottle over the banner, every time.

The NCCIH guidance on using supplements wisely and the FDA’s own questions and answers set out the framework in full, and the NIH Office of Dietary Supplements consumer fact sheet is the plainest single summary of it.

A metabolism capsule is a small lever. Used by somebody who already has the large levers moving, it is a reasonable thing to try for eight to twelve weeks with one measurement written down each week.

Bought as a substitute for them, it is a purchase that disappoints on a schedule: roughly three weeks, which is when the first-week stimulant novelty has worn off and nothing slower has arrived yet. That is the honest summary of everything above, and it holds whichever bottle you pick up.